Brazilian Organic-propolis Inhibits Anti-inflammatory Cytokines: in vitro and Bioinformatic Approaches
Objectives: Here, we evaluated the anti-inflammatory activity of seven types of Brazilian organic-propolis (OP) on activation of NF-κB transcription factor and TNF-α cytokine production in activated macrophages, as well as on the whole genome expression in HeLa cells. Methods: OP samples were collected in Paraná and Santa Catarina States, Brazil, in the region covered by the following coordinates: North and West: 24°41'16.6"S 52°12'28.5"W; East: 25°22'08.8"S 49°27'03.9"W; and South: 26°40'50.4"S 50°00'56.3"W, from February to June and December 2012. The samples were evaluated by thin layer chromatography and classified into seven chromatographic types. RAW 264.7 macrophages transfected with the NF-κB-pLUC gene were stimulated with LPS (100 ng/mL) for 4 hours at 37°C, 5% CO2. The viability of macrophages treated with the seven types of OP (0.1; 1; 10 and 100 µg/mL) was evaluated through the MTT assay. NF-kB activation was evaluated by luminescence intensity quantification (luciferase assay) and TNF-α was quantified through the ELISA assay. A translational pharmacogenomic study of OP effects was also carried out. HeLa cells were treated with OP and the whole-genome expression was evaluated using the HumanHT-12 BeadChip V4 system (Illumina). Results: The results showed that all types of OP were not toxic up to 100 µg/mL (p<0.05). Type 6 OP showed the best activity as it reduced NF-κB activation (50% inhibition) and TNF-α release (p<0.05). Regarding the activity on whole-genome expression, ten genes related with transmigration of leukocytes to the inflammatory focus were down-regulated upon treatment with Type 6 OP. Conclusions: This study demonstrates that Type 6 OP has promising activity by inhibiting the transmigration of leukocytes to the inflammation focus, which stands out as a potential source for the discovery of compounds with anti-inflammatory activity.
Division: IADR/AADR/CADR General Session
Meeting:2017 IADR/AADR/CADR General Session (San Francisco, California) Location: San Francisco, California
Year: 2017 Final Presentation ID:3529 Abstract Category|Abstract Category(s):Pharmacology/Therapeutics/Toxicology
Authors
Nani, Bruno
( University of Campinas State
, Piracicaba, SP
, Brazil
)
Murata, Ramiro
( East Carolina University
, Greenville
, North Carolina
, United States
)
Franchin, Marcelo
( University of Campinas State
, Piracicaba, SP
, Brazil
)
Tiveron, Ana Paula
( Luiz de Queiroz College of Agiculture
, Piracicaba
, São Paulo
, Brazil
)
Alencar, Severino
( Luiz de Queiroz College of Agiculture
, Piracicaba
, São Paulo
, Brazil
)
Rosalen, Pedro
( University of Campinas State
, Piracicaba, SP
, Brazil
)
Support Funding Agency/Grant Number: FAPESP (2012/22378-2 and 2012/01365-0)
Financial Interest Disclosure: None
SESSION INFORMATION
Poster Session
Pharmacology/Therapeutics/Toxicology III
Saturday,
03/25/2017
, 11:00AM - 12:15PM